| 靶点: |
EC50: 0.16 μM (GIRK1/2), 18 μM (GIRK1/4) |
| 体内研究: |
ML297 (60 mg/kg; i.p.) shows a highly significant ability to both prevent convulsions and prevent fatality of the PTZ treatment. |
| 参考文献: |
1. Wen W, et al. Discovery of 'molecular switches' within a GIRK activator scaffold that afford selective GIRK inhibitors. Bioorg Med Chem Lett. 2013 Aug 15;23(16):4562-6. 2. Kaufmann K, et al. ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice. ACS Chem Neurosci. 2013 Sep 18;4(9):1278-86. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.046 ml |
15.229 ml |
30.458 ml |
| 5 mM |
0.609 ml |
3.046 ml |
6.092 ml |
| 10 mM |
0.305 ml |
1.523 ml |
3.046 ml |
| 50 mM |
0.061 ml |
0.305 ml |
0.609 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |